PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 250 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2 | -99.9% | 60 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $3,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 60 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $5,000 | +25.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $4,000 | +33.3% | 60 | 0.0% | 0.00% | – |
| Q3 2021 | $3,000 | -25.0% | 60 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $4,000 | 0.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | 0.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | 0.0% | 60 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | +33.3% | 60 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | +50.0% | 60 | 0.0% | 0.00% | – |
| Q1 2020 | $2,000 | -33.3% | 60 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $3,000 | +50.0% | 60 | 0.0% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 60 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
| Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
| GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
| ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
| RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
| AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
| 1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
| ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
| OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
| Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |